Life Science

&alpha-CEHC is the major urinary metabolite of &alpha-tocopherol following vitamin E supplementation. The concentration of &alpha-CEHC in human serum is in the range of 5-10 pmol/ml but increases significantly up to 200 pmol/ml upon

&alpha-CEHC is the major urinary metabolite of &alpha-tocopherol following vitamin E supplementation. The concentration of &alpha-CEHC in human serum is in the range of 5-10 pmol/ml but increases significantly up to 200 pmol/ml upon

&alpha-CEHC is the major urinary metabolite of &alpha-tocopherol following vitamin E supplementation. The concentration of &alpha-CEHC in human serum is in the range of 5-10 pmol/ml but increases significantly up to 200 pmol/ml upon

Used to prepare various neoglycoproteins, which consist of a glycosylated serum albumin substituted with either fluorescein or methotrexate.

Used to prepare various neoglycoproteins, which consist of a glycosylated serum albumin substituted with either fluorescein or methotrexate.

Used to prepare various neoglycoproteins, which consist of a glycosylated serum albumin substituted with either fluorescein or methotrexate.

An intermediate in the interconversion of glucose and galactose.

An intermediate in the interconversion of glucose and galactose.

An intermediate in the interconversion of glucose and galactose.

An intermediate in the interconversion of glucose and galactose.

A derivative of glucose used to study carbohydrate metabolism, particularly in the identification, differentiation, and characterization of &alpha-phosphoglucomutase, &beta-phosphoglucomutase, and &alpha- and &beta-hexoglucomutases.

A derivative of glucose used to study carbohydrate metabolism, particularly in the identification, differentiation, and characterization of &alpha-phosphoglucomutase, &beta-phosphoglucomutase, and &alpha- and &beta-hexoglucomutases.